Literature DB >> 26640537

A voluminous mass as an initial clinical symptom of multiple myeloma: A case report.

Nicola Sgherza1, Angela Iacobazzi1, Angelantonio Cramarossa2, Giacoma DE Tullio1, Attilio Guarini1.   

Abstract

Extramedullary multiple myeloma (EMM) is a type of multiple myeloma (MM) that is defined by the presence of extraskeletal (soft tissue or visceral) clonal plasma cell infiltrates, which may be present at the time of initial diagnosis or at the time of relapse. Although extramedullary lesions may be present with other clinical features at the time of diagnosis, the onset of a solid formation as a first clinical symptom of MM is unusual. The present study reports the case of a 77-year-old male who was admitted to the Hematology Unit of the National Cancer Research Center, Istituto Tumori 'Giovanni Paolo II' (Bari, Italy) with a mass protruding from the right side of his lower back. Serum immunofixation revealed positivity for monoclonal protein (M-protein) and Bence Jones proteinuria was positive. In addition, a computed tomography scan of the abdomen, which was confirmed by magnetic resonance imaging, revealed a voluminous solid formation resembling a sarcoma. M-protein is known to be present in numerous diseases encountered in clinical practice, including hematological or other diseases; thus, a Tru-Cut biopsy of the lesion was performed, which revealed an infiltration of plasma cells. In addition, a bone marrow biopsy revealed the presence of 70% plasma cells, and a diagnosis of primary EMM was established. In conclusion, EMM should be included in the differential diagnosis of a mass, particularly in patients where M-protein is detected in the blood and/or urine.

Entities:  

Keywords:  extramedullary multiple myeloma; imaging techniques in multiple myeloma

Year:  2015        PMID: 26640537      PMCID: PMC4665678          DOI: 10.3892/etm.2015.2720

Source DB:  PubMed          Journal:  Exp Ther Med        ISSN: 1792-0981            Impact factor:   2.447


  13 in total

1.  Solitary bone and extramedullary plasmacytoma.

Authors:  Donna M Weber
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2005

2.  Whole-body MRI in the detection of bone marrow infiltration in patients with plasma cell neoplasms in comparison to the radiological skeletal survey.

Authors:  Nadir Ghanem; Christian Lohrmann; Monika Engelhardt; Gregor Pache; Markus Uhl; Ulrich Saueressig; Elmar Kotter; Mathias Langer
Journal:  Eur Radiol       Date:  2006-02-04       Impact factor: 5.315

3.  Whole-body (18)F-FDG PET identifies high-risk myeloma.

Authors:  Brian G M Durie; Alan D Waxman; Allesandro D'Agnolo; Cindy M Williams
Journal:  J Nucl Med       Date:  2002-11       Impact factor: 10.057

Review 4.  Molecular imaging in myeloma precursor disease.

Authors:  Esther Mena; Peter Choyke; Esther Tan; Ola Landgren; Karen Kurdziel
Journal:  Semin Hematol       Date:  2011-01       Impact factor: 3.851

Review 5.  Multiple myeloma with extramedullary disease.

Authors:  Albert Oriol
Journal:  Adv Ther       Date:  2011-11-11       Impact factor: 3.845

6.  Cancer statistics, 2010.

Authors:  Ahmedin Jemal; Rebecca Siegel; Jiaquan Xu; Elizabeth Ward
Journal:  CA Cancer J Clin       Date:  2010-07-07       Impact factor: 508.702

Review 7.  Multiple myeloma.

Authors:  Jean-Luc Harousseau; John Shaughnessy; Paul Richardson
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2004

Review 8.  Treatment of multiple myeloma.

Authors:  S Vincent Rajkumar
Journal:  Nat Rev Clin Oncol       Date:  2011-04-26       Impact factor: 66.675

9.  Criteria for the classification of monoclonal gammopathies, multiple myeloma and related disorders: a report of the International Myeloma Working Group.

Authors: 
Journal:  Br J Haematol       Date:  2003-06       Impact factor: 6.998

Review 10.  Multiple myeloma: 2014 Update on diagnosis, risk-stratification, and management.

Authors:  S Vincent Rajkumar
Journal:  Am J Hematol       Date:  2014-10       Impact factor: 10.047

View more
  1 in total

1.  Atypical Presentation of Plasma Cell Neoplasm of the Sternum.

Authors:  Ndausung Udongwo; Steven Douedi; Mihir Odak; Abbas Alshami; Swapnil V Patel; Taliya Farooq
Journal:  Cureus       Date:  2021-07-02
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.